For the Inventor, By the Inventor

Enter assignee name

I.d.m. Immuno-designed Molecules

USPTO Granted Patents = 17

Forward Citations = 136

Loading Chart...

Loading Chart...

14 inventors (with patents filed for the assignee):

Jacques Bartholeyns (9 out of 12 patents)

Mohamed Chokri (9 out of 10 patents)

Jean-Loup Romet-Lemonne (6 out of 6 patents)

4. Michel Monsigny (4 out of 11 patents)

5. Patrick Midoux (3 out of 3 patents)

6. Yves Fouron (2 out of 6 patents)

7. Annie-Claude Roche-Degremont (2 out of 2 patents)

8. Patrick Erbacher (2 out of 2 patents)

9. Claire Boccaccio (1 out of 1 patent)

10. Jean-Pierre Abastado (1 out of 4 patents)

11. Alessandra Nardin (1 out of 2 patents)

12. Roger Mayer (1 out of 2 patents)

13. Nadia Sdiqui (1 out of 1 patent)

14. Annie-Claude Roche (1 out of 2 patents)

17 patents: Sort by Forward Citations

1. 7252996 - Ancillary composition for the preparation of committed mature dentritic cells (2007-08-07),

2. 6881413 - Humanized biomaterials, a process for their preparation and their applications (2005-04-19),

3. 6821516 - Macrophages, process for preparing the same and their use as active substances of pharmaceutical compositions (2004-11-23),

4. 6713056 - Combined preparation for the treatment of neoplasic diseases or of infectious diseases (2004-03-30),

5. 6616925 - Combined preparation for the treatment of neoplasic diseases or of infectious diseases (2003-09-09),

6. 6596275 - Monocyte derived cells with immunosuppressive properties, process for their preparation and their uses in pharmaceutical compositions (2003-07-22),

7. 6540994 - Macrophages, process for preparing the same and their use as active substances of pharmaceutical compositions (2003-04-01),

8. 6372499 - Polymeric complexes for the transfection of nucleic acids, with residues causing the destabilisation of cell membranes (2002-04-16),

9. 6251858 - Derivatives of oligosides, their process of preparation and their applications (2001-06-26),

10. 6221576 - Process for preparing macrophages, kits, and compositions for the use of this process (2001-04-24),

11. 6140122 - Process for preparing macrophages, kits, and compositions for the use of (2000-10-31),

12. 6051432 - Macrophages, process for preparing the same and their use as active (2000-04-18),

13. 6001351 - Macrophages, process for preparing the same and their use as active (1999-12-14),

14. 5804442 - Process for preparing macrophages, kits, and composition for the use of (1998-09-08),

15. 5733762 - Complexes of nucleic acid and polymer, their process of preparation and (1998-03-31),

I.d.m. Immuno-designed Molecules is a biotechnology company focused on developing innovative therapies for cancer and autoimmune diseases. Founded in 2010, I.d.m. is known for its expertise in designing and developing novel immunotherapies that target specific molecular pathways involved in disease progression. The company's pipeline includes several promising drug candidates that are currently in preclinical and clinical development stages.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

17 Patents

#245 in Paris

#1,127 in France

#34,819 in the World

I.d.m. Immuno-designed Molecules

Forward Citations = 136

14 inventors:

Jacques Bartholeyns (9 out of 12 patents)

Mohamed Chokri (9 out of 10 patents)

Jean-Loup Romet-Lemonne (6 out of 6 patents)

4. Michel Monsigny (4 out of 11 patents)

5. Patrick Midoux (3 out of 3 patents)

Please report any incorrect information to support@idiyas.com

Loading…